Ipilimumab plus sargramostim vs ipilimumab alone for treatment of metastatic melanoma: a randomized clinical trial
JAMA (2014) - Comments
pubmed: 25369488  doi: 10.1001/jama.2014.13943  issn: 1538-3598  issn: 0098-7484 

F. Stephen Hodi, Sandra Lee, David F. McDermott, Uma N. Rao, Lisa H. Butterfield, Ahmad A. Tarhini, Philip Leming, Igor Puzanov, Donghoon Shin, John M. Kirkwood